Therapy response and actuarial probability of survival at 60 months in relation to EVI1 and MDS1-EVI1expression
| . | n . | Complete remission, no. (%) . | Actuarial probability of survival at 60 mo, % . | Relapse, no. (%) . | |
|---|---|---|---|---|---|
| EFS . | OS . | ||||
| Group I,EVI1+ andMDS1-EVI1− | 6 | 3 (50) | 0 | 0 | 1 (33) |
| Group II, EVI1+ andMDS1-EVI1+ | 26 | 20 (77) | 4 | 8 | 15 (75) |
| Group III, EVI1− andMDS1-EVI1+ | 12 | 8 (67) | 25 | 33 | 3 (38) |
| Group IV, EVI1− andMDS1-EVI1− | 275 | 218 (79) | 27 | 33 | 100 (46) |
| . | n . | Complete remission, no. (%) . | Actuarial probability of survival at 60 mo, % . | Relapse, no. (%) . | |
|---|---|---|---|---|---|
| EFS . | OS . | ||||
| Group I,EVI1+ andMDS1-EVI1− | 6 | 3 (50) | 0 | 0 | 1 (33) |
| Group II, EVI1+ andMDS1-EVI1+ | 26 | 20 (77) | 4 | 8 | 15 (75) |
| Group III, EVI1− andMDS1-EVI1+ | 12 | 8 (67) | 25 | 33 | 3 (38) |
| Group IV, EVI1− andMDS1-EVI1− | 275 | 218 (79) | 27 | 33 | 100 (46) |